Marshall Wace’s ContraFect Corporation CFRX Stock Holding History

Marshall Wace’s Portfolio CFRX Stock Details CFRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-649	Closed	-$229K	–	3679
2021 Q2	$229K	Buy	+649	New	+$212K	﹤0.01%	2413

Other funds holding CFRX

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

MCM

Moore Capital Management New York $4.92B AUM 35.41% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Marshall Wace's CFRX Position: Q3 2021 in Review

Marshall Wace sold out of ContraFect Corporation (CFRX) in Q3 2021, closing a stake of 649 shares — an estimated $229K sold.

Marshall Wace first reported a position in CFRX in Q2 2021 and held it in 1 quarter. The position peaked at $229K in Q2 2021. 56 funds tracked by Wall St. Rank hold CFRX as of Q3 2021.

Marshall Wace reported no remaining ContraFect Corporation position as of Q3 2021 after selling out during the quarter.
Marshall Wace sold 649 ContraFect Corporation shares in Q3 2021, an estimated $229K.
Marshall Wace first reported a position in ContraFect Corporation in Q2 2021 and held it in 1 quarter.
Marshall Wace's ContraFect Corporation position peaked at $229K in Q2 2021.
56 funds tracked by Wall St. Rank held ContraFect Corporation as of Q3 2021.

Based on Marshall Wace's 13F filing for Q3 2021, filed 15 Nov 2021.